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Nature’s lessons in design: nanomachines to scaﬀold,
remodel and shape membrane compartments
Paul A. Beales,*a Barbara Ciani*bc and Alexa J. Cleasbybc
Compartmentalisation of cellular processes is fundamental to regulation of metabolism in Eukaryotic
organisms and is primarily provided by membrane-bound organelles. These organelles are dynamic
structures whose membrane barriers are continually shaped, remodelled and scaﬀolded by a rich variety
of highly sophisticated protein complexes. Towards the goal of bottom-up assembly of compartmentalised
protocells in synthetic biology, we believe it will be important to harness and reconstitute the membrane
shaping and sculpting characteristics of natural cells. We review diﬀerent in vitro membrane models and
how biophysical investigations of minimal systems combined with appropriate theoretical modelling have
been used to gain new insights into the intricate mechanisms of these membrane nanomachines, paying
particular attention to proteins involved in membrane fusion, fission and cytoskeletal scaﬀolding processes.
We argue that minimal machineries need to be developed and optimised for employment in artificial
protocell systems rather than the complex environs of a living organism. Thus, well-characterised minimal
components might be predictably combined into functional, compartmentalised protocellular materials that
can be engineered for wide-ranging applications.
Introduction
Scientists have long looked to nature to provide solutions to
some of our greatest problems, from therapeutics and medical
materials, to the environment and energy production. As the
oft-quoted physicist Richard Feynman said ‘nature’s imagination
is so much greater than man’s, she’s never going to let us relax.’
This statement couldn’t be more evident than in the stun-
ningly complex and vastly interlinked systems that make up
each and every living cell. Cells are some of the most incredibly
adept devices we know and understanding them is the first step
towards manipulating and harnessing cells as machines and
applying them in novel ways.
One of the cell’s most ingenious skills is also one of its most
simple: compartmentalisation. Cell biologists have been intri-
gued for decades by the organisational abilities of cells and their
clever methods of compartmentalisation. The ability to keeps
things separate sounds simple, and yet, behind the scenes
lies hundreds of interacting proteins and precise pathways that
orchestrate and permit a multitude of mini-reactions to occur
independently, repeatedly and simultaneously in the space of
one cell. Eduard Buchner commented in his 1907 Nobel Lecture
that ‘We are seeing cells more and more clearly as chemical
factories, where the various products are manufactured in separate
workshops, the enzymes acting as the overseers.’
This same complexity is one reason designing experiments
to exclusively probe one aspect of a cell’s function can be near
impossible in vivo, and yield results diﬃcult to interpret. Cell
biology relies heavily on the use of model systems, which have
considerably furthered the current understanding of how cells
work, but lack the finer mechanistic detail.
Synthetic biology† or reconstitution studies, addresses this
issue by oﬀering a powerful way to study proteins in a stripped
down system that can be tightly controlled. Liu & Fletcher1 outline
the benefits succinctly; in vitro experiments can refine and
confirm molecular processes outside of a complicating cellular
environment, whilst providing insight into how these biological
functions could be engineered towards new functions. It is this
idea that lies at the heart of synthetic biology; creating an inter-
face between biology and engineering and the understanding to
turn cell biology into a physical and engineering discipline.
It’s important to appreciate there is so much more to
synthetic biology than uncovering the secrets of how cells work.
In vitro reconstitution experiments are slowly revealing a whole
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which is yet to be realised and with only man’s imagination as
the limit to the possibilities. Occurring throughout cells,
dynamic membrane remodelling is gained by the precise inter-
play of proteins and lipids that are able to generate, sense and
stabilise membrane curvature.
Here, we introduce a handful of these proteins and the
experimental setups that enabled the study of the mechanisms
through which they shape membranes, together with examples
of how this knowledge has been used to produce minimal
systems of membrane remodelling tools. The scope of this
review is to present advances in recent in vitro studies of
membrane deformation mechanisms by natural systems as
an opportunity for developing new instruments for the genera-
tion of ad hoc compartments leading to the engineering of
functional protocells. First we give an overview of diﬀerent
model membrane systems and how they are best applied in
studying these protein–membrane interactions and construc-
tion of protocellular systems. We then review recent mecha-
nistic insights into the function of proteins involved in the
sculpting and scaffolding of membranes gained from bio-
physical studies on reconstituted minimal systems. This leads
us into a brief overview of the theory of membrane elasticity
and the important additional insights of combining appropri-
ate theoretical models with biophysical experiments in under-
standing biological mechanism. These biophysical insights
form the basis of a discussion of how these lessons from nature
can be best applied to the design of protocellular materials
where we argue the merits of designing minimal machineries
optimised for in vitro function and give recent examples of such
reengineered or biomimetic nanomachines. We close with an
outlook for the future development of nanomachines for
dynamic control of compartmentalisation in engineered proto-
cells, proposing how the field might proceed from biophysical
insight of natural machineries to biological components that
can be engineered into predictable protocellular machines.
Setting boundaries: in vitro model
membrane systems
A range of model membrane systems exist that are useful for
the study of reconstituted proteins and protein complexes.
These can be categorised into supported membranes, which
are membranes that have been formed on a supporting sub-
strate, and unsupported membranes, which are unconstrained
membranes that are free-floating in solution. While, as we will
see, unsupported membrane systems have the greatest capacity
for encapsulation of chemical processes, supported membrane
systems allow the application of powerful surface-analytical
techniques to the study of protein–membrane interactions.
Substrate-supported membranes
Supported membranes can be formed upon a variety of solid
substrates, with commonly used substrate materials including
mica, gold, quartz and glass.2 These solid supports rigidly
confine the membrane to their surface and thereby suppress
the membrane’s freedom to bend in response to interactions
with proteins and other membrane-active matter. The attractive
interactions that are required to exist between the membrane
and its support in order for it to remain confined to its surface
may also have other perturbations on the properties of these
membranes that do not exist in unsupported systems. For
example, changes in membrane dynamical properties are well
known: lateral diﬀusion coeﬃcients of lipids in surface sup-
ported membranes can be significantly slower than in unsup-
ported model membranes.3 Furthermore, the morphology and
dynamics of lipid domains in phase-separated membranes
can exhibit significant diﬀerences between supported and
unsupported membrane models.4–8 Despite these possible
disadvantages, surface-supported systems are still widely used
to study lipid membranes. The primary reason for this is the
range of surface analytical techniques that allow membranes
to be studied with greater resolution and sensitivity than is
often achievable with unsupported model membranes. These
techniques include atomic force microscopy (AFM) for high
resolution topological imaging,4,5,7,9 AFM and surface force
apparatus for measuring the mechanical forces and interaction
forces of membranes,10 quartz crystal microbalance,11,12 surface
plasmon resonance13 and total internal reflection fluorescence
microscopy (TIRF-M)14 for membrane binding interactions,
membrane electrochemistry (e.g. supported membranes on gold
electrodes)15 and time-of-flight secondary ion mass spectrometry
imaging for studying the lateral distribution of chemical compo-
sition within a membrane.16
A variety of methods exist for creating substrate-supported
model membranes. The most commonly used techniques are
the vesicle fusion method, where small or large unilamellar
vesicles, which are dispersed in an aqueous solution above the
substrate, fuse with the supporting surface to form a single
lipid bilayer, and the Langmuir–Blodgett (LB) method, where
the substrate is passed twice through a lipid monolayer formed
at an air–water interface by dipping the cleaned solid-surface into
and out of the aqueous phase.17 Several methods have also been
developed to create asymmetric supported lipid bilayers where
each lipid monolayer has a different lipid composition.18–20 This
mimics the lipid asymmetry known to occur in natural membranes
and allows characterisation of how such asymmetry modulates the
physical properties and behaviour of the membrane.
Due to solid membrane substrates not generally being
relevant as natural biological interfaces and their hindrance for
incorporation of transmembrane proteins, softer supports
have been developed. These include supported membranes on
polymer cushions or hydrogels and membranes extended from
the surface by ‘‘molecular stilts’’: functionalised lipids such as
oligoethylene glycols with a thiol functionality at one end for
covalent surface attachment and a sterol at the other to insert
into the hydrophobic core of the membrane.21–25 Furthermore,
techniques have been developed to create regions of unsupported
membrane within a supported lipid membrane by forming the
bilayer atop a microfabricated substrate that contains small
holes. The supported membrane does not enter these holes but
rather spans the gap, providing regions of membrane that do not
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directly interact with the substrate.26–28 Finally it should be noted
that supported membranes have been formed on the surface
of colloidal particles; this allows the dispersion of supported
membranes into bulk solution and introduces curvature to the
membranes comparable to those found in biological cells and
organelles.29,30
Unsupported membranes
Unsupported membranes allow dispersion of lipid bilayers into
the aqueous phase without the need for a supporting substrate.
Several such model systems exist; we will briefly introduce lipid
nanodiscs, droplet interface bilayers and small, large and giant
unilamellar vesicles. We will give most emphasis to giant uni-
lamellar vesicles (GUVs) as these are cell-sizedmodel membranes
capable of encapsulating chemical processes. Furthermore, GUVs
are themost commonmodel membrane used in the literature for
reconstitution of functional protein complexes.
(a) Lipid nanodiscs are lipid bilayer micelles whose edge
tension is stabilised by a-helical scaﬀold proteins.31,32 Depending
on the scaﬀold protein that is employed, these disc-like
membrane fragments vary in diameter between approximately
10–18 nm with a narrow size distribution.33 These model
membranes have primarily been employed as a more bio-
logically relevant alternative to detergent solubilisation of integral
membrane proteins for structural and functional assays.34–36 Most
relevant to the study of membrane remodelling protein complexes
is the use of lipid nanodiscs for single molecule fluorescence
spectroscopy studies.37 Due to the small surface area of
membrane available on a lipid nanodisc, experimental protocols
can be designed such that only a single protein or protein
complex will interact with a nanodisc. This scenario is much
harder to achieve using model membrane systems based upon
lipid vesicles, which have a much larger surface area per particle
for interactions to take place and the number of interacting
proteins per lipidic particle would follow a Poisson distribution.
(b) Droplet Interface Bilayers (DIBs) are formed using water-
in-oil emulsions.38 Water droplets dispersed in an oil contain-
ing dissolved lipids recruit a lipid monolayer to the oil–water
interface. When two of these droplets are brought into
contact, oil is excluded from the interfacial region between
the droplets such that a lipid bilayer membrane forms
between the two aqueous compartments. Electrophysiological
measurements have been used to study the ion permeability of
these membranes in the presence of integral and peripheral
membrane proteins.39–41 Experimental geometries have also
been developed that allow simultaneous electrophysiological
and fluorescence microscopy studies.42 As we will see, DIBs
are also a starting point for some of the more advanced
methods for fabrication of GUV model membranes. Notably,
DIBs and vesicles, which will be discussed below, have the
capacity to compartmentalise chemical entities and processes
within an encapsulated volume and therefore are prime for a
stepwise increase in complexity of reconstituted biological
systems towards the bottom-up development of artificial cells
and tissues.
(c) Small or Large Unilamellar Vesicles (SUVs or LUVs) are
nanoscale or sub-micrometer unsupported membrane shells
with an encapsulated aqueous compartment segregated from
the bulk water phase. SUVs (o100 nm diameter) are usually
formed by high energy sonication of multilamellar vesicles
(MLVs; formed by the dispersion of dried lipid films into an
aqueous buﬀer by vortexing).43 LUVs (100–1000 nm diameter)
can be formed by several different methods; most commonly
they are formed by multiple extrusions of MLVs through poly-
carbonate filters with monodisperse pore sizes of between
100–400 nm. Alternatively they can be formed by reverse phase
evaporation or detergent extraction methods. Aqueous vesicle
dispersions are often studied by spectroscopic or calorimetry
techniques that report the statistical ensemble averaged beha-
viour of a large population of vesicles; example techniques
include isothermal titration calorimetry, fluorescence spectro-
scopy, dynamic light scattering, electrophoretic light scattering
and electron spin resonance spectroscopy. More recently tech-
niques have been developed that allow single vesicle analysis
of sub-micrometer vesicles, e.g. by anchoring these vesicles
to a surface and using spatially-resolved surface analytical
techniques.44,45 One of the advantages of SUV and LUV systems
is the ability to create membranes of high curvature, thus
allowing systematic study of curvature-dependent effects that
influence protein–membrane interactions.46–48
(d) Giant Unilamellar Vesicles (GUVs) are vesicles that are
41 mm in diameter (most typically in the range of 10–30 mm)
and so are observable by optical microscopy techniques. This
allows experimental observations to be conducted at the single
vesicle level. Beyond the average behaviour of a sample, single
vesicle analysis can reveal the full distribution of vesicle
behaviours, transient intermediate states and is sensitive to
rare events. Due to their large size (similar to that of biological
cells), GUV membranes have low curvature and are usually
considered to be effectively flat for the purposes of interactions
with nanoscale proteins and protein complexes. However
methods have been developed to study curvature effects in GUVs
by extruding cylindrical lipid tubules from the GUV surface that
are a few tens of nanometers in diameter: the cylindrical
curvature of these structures implies high curvature for only
one of the two principal curvatures of the membrane, the second
principal curvature being equal to zero.49–51 For high spherical
membrane curvature (both principal curvatures are high), then
SUVs or LUVs are more appropriate model systems.
While optical microscopy is often used to study GUVs, GUV
experimental analysis can go well beyond the recording
of qualitative pictures, as summarised in Table 1. Dense (e.g.
sugar) solutions are often encapsulated within GUVs such that
the encapsulated phase is more dense than the surrounding
solution, causing the vesicles to sediment to the bottom of the
sample dish, making them easier to find and observe.52 Methods
have also been developed that allow reconstitution of integral
membrane proteins into GUV model membranes.53
Methods for preparation of GUVs are summarised in Fig. 1.
The most popular method for GUV production is the electro-
formation method.54,55 Lipid films are dried from chloroform
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stock solutions onto Pt wire or ITO-coated glass electrodes.
After rehydration with an aqueous solution (often a sucrose
solution), an a.c. electric field protocol is applied to the
electrodes for 1–2 h. The initial sine wave a.c. frequency usually
ranges between 10–20 Hz and many protocols gradually reduce
this frequency in a stepwise fashion during the electroforma-
tion procedure. The amplitude of the a.c. field that is used
usually varies between 1.5–5 V, with the lower end of this range
more appropriate when charged lipids form part of the lipid
mixture. While electroformation usually produces a high yield
of high quality GUVs, disadvantages of this method are that
high salt or high (B>20 mol%) anionic lipid content signifi-
cantly suppress GUV yield or prevent their formation alto-
gether. However it should be noted that this technique works
very well for phosphocholine-rich membranes, the most pre-
dominant lipid type in Eukaryotic membranes. Physiological
salt buffer can be added to the extravesicular medium after
electroformation is complete. Protocols using a higher frequency
a.c. field have been reported that facilitate GUV formation in
physiological salt buffers.56 Alternatively, the gentle hydration
method can be used to form GUVs, but this method gives a lower
yield of high quality GUVs.57 Recently formation of GUVs assisted
by a polyvinyl alcohol gel support has been reported that permits
a wide range of lipid compositions and buffer conditions to
be used.58
A further disadvantage of these GUV preparation methods is
the challenge of encapsulation of diﬀerent chemical entities
inside GUVs compared to those in the extra-vesicular aqueous
solution. Upon forming the GUVs in the presence of compounds
required for encapsulation, similar concentrations will be present
inside and outside the vesicles. Separation of unencapsulated
compounds from the sample is challenging, with tradition
approaches used for LUVs, such as size exclusion chromato-
graphy or dialysis, proving to be ineﬃcient. More recent devel-
opments in GUV fabrication methods use emulsion-based
assembly protocols and allow more eﬃcient specific encapsula-
tion of compounds. Emulsion phase transfer methods are based
on the transfer of lipid stabilised water-in-oil droplets through an
Table 1 Overview of some of the experimental techniques used to study GUV membranes, including many quantitative microscopy measurements
Measurement Technique Brief description and comments
Key and example
references
Membrane
morphology
Optical microscopy GUV morphology changes directly observed by optical microscopy (phase contrast,
epifluorescence, fluorescence confocal) can give qualitative clues to the nature of
material interactions with the membrane.
52, 166
Membrane
fluidity
Fluorescence recovery
after photobleaching
(FRAP)
A region of the membrane is bleached of fluorescence with a high energy laser of a
confocal microscope. The rate of fluorescence recovery by dyes from outside of the
region of interest can be quantified into a lateral diﬀusion constant of lipids. This
methods assumes homogeneous diﬀusion across a larger area of membrane
(i.e. the photobleached region)
164, 170, 171
Fluorescence correlation
spectroscopy (FCS)
The autocorrelation function of fluorescence fluctuations of a pixel on the GUV
membrane is used to quantify the diﬀusion constant of fluorophore-labelled lipids
or membrane-bound proteins. This is a more localised measurement than FRAP
(above) and can be confined to the nanoscale using stimulated emission depletion
microscopy FCS (STED-FCS172,173).
172–180
Mechanical
moduli
Micropipette aspiration GUVs are aspirated into a micropipette; stress-strain plots are used to quantify kb,
KA and the lysis stress and strain. kb is diﬃcult to measure as this requires a lot of
data points in the low tension regime. Membrane contour analysis (below) can be
better for measuring kb.
123–125, 181, 182
Membrane contour
analysis
The radial localisation of the GUV’s membrane is determined with sub-pixel
resolution. Fitting the power spectrum of membrane fluctuations allows the
bending modulus to be quantified.
183–188
Membrane
permeability
Dye translocation
kinetics
The rate of influx of water soluble fluorescent probes into GUVs can be used to
quantify the membrane’s permeability and the fractional permeable area of
membrane.
189–191
Patch-clamp
electrophysiology
Electrophysiological patch-clamp recordings have been achieved in GUVs to
quantify ion permeability of membranes.
192
Membrane
phase behaviour
Fluorescent lipid
partitioning
Imaging the partitioning of dyes between coexisting lipid phases in phase
separated membranes allow the study of membrane phase behaviour and the
construction of phase diagrams of lipid mixtures.
193
Lipid packing
and hydration
Laurdan fluorescence The generalised polarisation function of Laurdan obtained from ratiometric
imaging of two environment-sensitive emissionmaxima reveals information about
changes in the local structure and hydration of the membrane.
165, 194, 195
Membrane
binding
Fluorescence
localisation imaging
Imaging of fluorescent membrane-active compounds (e.g. proteins) can be used
to semi-quantitatively investigate their binding at GUV membranes, including
relative binding to diﬀerent coexisting membrane phases or curvatures.
49, 52, 99
Flow cytometry The colocalisation of fluorescent proteins or particles with GUVs in flow cytometry
experiments can be used to quantify the kinetics and extent of adsorption.
196
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oil–water interface, where it picks up a second lipid monolayer,
resulting in formation of a completed GUV in water with encap-
sulated contents.59 This method can also be adapted to produce
asymmetric membranes.60 Microfluidic lab-on-a-chip methods
are being developed for GUV fabrication, in particular using
flow-focussing droplet microfluidics geometries.61,62 Recently
droplet microfluidics and emulsion phase transfer strategies
have been combined into a single on-chip GUV fabrication
protocol.63 Microfluidic jetting has also been reported using DIBs
as a starting point for GUV formation; jets of fluid cause GUVs to
break away from the DIB.64 This method can be used for high
encapsulation efficiency and formation of asymmetric mem-
branes.65 DIBs in conjunction with the emulsion phase transfer
method have been used to create multicompartment GUVs.66,67
Structure translates into function for
membrane-bound compartments
The cell cytoplasm is crowded with molecules that each belong to
diﬀerent pathways. Membrane organelles organise cell content
and streamline cellular functions. These membrane-bound
compartments allow small molecules to permeate by diﬀusion
whereas larger cargoes are encapsulated through remodelling of
their surfaces in a process called endocytosis (Fig. 2). Phospho-
lipid membranes provide organelles with unique morphologies
that define their functions. Intracellular membrane organelles
have highly complex shapes with a common characteristic: their
large membrane area in comparison to the volume they enclose.
Endoplasmic reticulum and Golgi apparatus membranes adopt
typical tubulated structures, acting as storage and processing
units for vesicular cargoes. Membrane tubules are also a feature
of early endosomes, organelles that capture vesicles originated
from endocytosed cargo and ‘mature’ into multivesicular bodies
while moving along microtubules tracks (Fig. 3). While early
endosomes adopt irregular structures, MVBs consist of vesicles
inside larger vesicles that are conduits for compartmentalisation,
sorting and transport of material to selected destinations68
(Fig. 3). There is a biological reason for this variety in organelle
shape: larger surface areas facilitate cargo exchange between the
intraluminal space of the organelle and the cytosol. Furthermore,
larger surfaces allow for eﬃcient separation of cargo at the
membrane. This structure–function relationship existing in intra-
cellular membrane compartments would ideally be translated
into synthetic cellular systems to optimise their functional cap-
abilities and efficiencies. So what is shaping membrane-bound
compartments in functional biological cells?
Tools for the job: in vitro reconstitution
of molecular systems for sculpting
membranes
The complex shape of intracellular organelles is moulded by
physical forces acting on phospholipid membrane bilayers.
The mechanical tools exerting localised forces that induce
membranes’ deformation are organised assemblies of proteins
that recognise, anchor and remodel vesicular structures. There
are two main types of membrane remodelling events: fusion
and fission. Here we will cover some of the most recent work
aimed at understanding how structures of individual and
assembled proteins drive these processes.
Membrane fusion
Membrane fusion occurs in a wide variety of cellular activities,
especially those that involve endocytosis or exocytosis of material.69
Fig. 1 Overview of some of the GUV formation methods. (a) electroformation; (b) emulsion-transfer method; (c) microfluidic double emulsions; (d)
microfluidic jetting.
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It has only been in the last two decades that the molecular
machinery and mechanisms of membrane fusion have been
uncovered. Molecules, or ‘cargo’, are constantly being moved
around cellular compartments and delivered to precise intracellular
destinations. This traﬃc and transport of cargoes in, out and
throughout the cell occurs without compromising the structure
of any cellular organelle thereby leaking their contents; this
is achieved via fission and fusion of membrane vesicles.
Fig. 3 Cellular fission and fusion events in traﬃcking of cargo viamembrane compartments. Endocytosed cargo is enveloped in clathrin coated vesicles
(red), with the aid of fission proteins (BAR and ENTH domains). Clathrin-coated vesicles are incorporated into early endosomal structures. The tubules of
endosome membranes are shaped by molecular motors (kinesin, dynein), while moving along microtubule (blue arrows) towards the centre of the cell.
Some vesicular cargo is also recycled to the cell surface. During movement, the endosomes ‘mature’ into multivesicular bodies (MVB), changing their
shape and protein composition (yellow area). MVBs are generated by accumulation of cargo destined for degradation by the lysosome (pink area) via
membrane budding and scission events performed by the ESCRT complexes. The trans-Golgi network (TGN) is another sorting station for vesicular cargo
that utilises COPI protein coats for membrane scaﬀolding. This figure is a derivative of Fig. 1 from ref. 68, used under CC BY 3.0 licence.
Fig. 2 Key cellular events that require membrane fission and fusion. Membrane fission is typical of events such as endocytosis. It is necessary for the
generation of transport vesicles, which fuse with sorting stations, namely the endosomes and the multivesicular bodies. Membrane fusion events are
typical of exocytosis processes, such viral particles budding and the release of exosomal vesicles.
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Transport vesicles filled with cargo bud from a donor organelle,
and are then transported to an acceptor organelle, where they
dock to the membrane and fuse, thereby releasing their cargo
(Fig. 3). Here we look at some of the main structural and
mechanistic aspects of the main players in membrane fusion
and targeting: SNARE complexes.
SNAREs. The main molecular machinery that performs
membrane fusion is a specialised set of coiled coil proteins
called SNAREs (Soluble NSF Attachment Protein REceptor).
SNARE proteins selectively target a vesicle to its destination
by matching up a SNARE protein on a vesicle (v-SNARE) with
a corresponding SNARE protein on the target membrane
(t-SNARE). Vesicle fusion involves many coordinated steps,
including the formation of a tetrameric a-helical coiled coil
bundle (Fig. 4a). Once tethered to the membrane, through this
t-/v-SNARE complex, the vesicle undergoes several ‘priming’
events to prepare it for fusion. An influx of calcium ions acts
as the trigger to begin fusion. There are over 60 SNAREs
identified in yeast and mammalian cells, found in distinct
intracellular compartments throughout the cell and implicated
in the vast majority of membrane traﬃcking events.70 SNAREs
were first purified by So¨llner et al.71 who proposed a ‘SNARE
hypothesis’ that a stoichiometric complex is formed consisting
of anchoring and tethering v- and t-SNAREs located on donor
and acceptor membranes (Fig. 4b); a cytosolic accessory fusion
protein SNAP and the enzyme NSF (N-ethylmaleimide-sensitive
factor) are necessary for SNARE complex disassembly. The
SNARE hypothesis postulates that fusion is driven by the close
proximity of membranes brought about by the specific inter-
action of a certain vesicle and target SNAREs.
The first observation of content mixing was seen using an
in vitro fluorescence-based assay using liposomes.72 This work
suggested SNARE proteins form the minimum machinery
required for fusion. SNARE complexes are specific, as v-SNAREs
do not interact with other v-SNARE containing liposomes or
protein free vesicles. The interaction occurs via a unique
hairpin-like structure formed by the SNARE complex, named
SNAREpin, and is similar to structures formed by some viral
fusion proteins.73 The Weber paper has been cited ~2000 times
since its publication in 1998 and received much attention, not
only due to the cell biology questions it answered, but also the
prospect of studying membrane fusion in a fully reconstituted
system.
Assembly of a stable SNARE complex occurs spontaneously in
solution when using free SNAREs and is energetically favourable.
In cells this is controlled by a series of regulatory proteins,
but can formation of the SNARE complex and fusion be
controlled in synthetic cell systems? SNARE complexes can
assemble before fusion and these unfused intermediates accu-
mulate at lower temperatures, therefore something other than
high concentrations is required to induce fusion. It was noticed
that prefusion ‘priming’ steps occur more slowly in a cell free
system, possibly as the proteins need to topically rearrange
themselves into a circular array to give rise to the ‘fusion pore’
(Fig. 4b) that initiates fusion.74,75 Some viral proteins behave in
a similar fashion, forming pre-fusion intermediates at low tem-
peratures that only fuse once the temperature has increased or
been triggered by a low pH (such as within a late endosome).76
Lipid bilayer nanodiscs were used recently to demonstrate
that one SNARE only is required for maximum rates of
membrane fusion, but release of membrane contents on
physiological timescales requires zippering of multiple SNAREs
into SNAREpin structures, suggesting that SNARE complexes
prevent the fusion pore from resealing during cargo release.77
SNARE-driven fusion in liposomes occurs at rates comparable
to physiological fusion following removal of an inhibitory
N-terminal domain in t-SNAREs, without aﬀecting the rate of
the v- t-SNARE complex formation itself. Full length v-/t-SNARE
reconstituted liposomes in the presence of Ca2+ also enables
membrane fusion at near physiological rate, confirming the
role of Ca2+ as a regulatory factor in fusion.78
The size of the lipid vesicles and the lipid composition itself
may also aﬀect the eﬃciency of fusion. For instance, recently
we have learned that for physiological concentrations of SNARE
Fig. 4 Mechanism of membrane fusion and fission by SNARE complexes. (a) Tetrameric coiled coil structure of an assembled neuronal SNARE complex
involved in synaptic exocytosis (pdb code 1SFC). (b) Complementary v- and t-SNARE coiled coils sitting on donor vesicle and target membranes ‘zipper’
to bring the bilayers closer and initiate ‘fusion pore’ formation. The individual a-helical coiled coil chains in (a) and the respective cartoons representations
in (b) are identically colour coded.
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proteins to perform eﬃcient membrane fusion there is a
specific requirement for small neutral lipids that do not form
bilayer structures (i.e., phosphatidylethanolamine). In the
absence of these types of lipids, vesicles can still dock and
form trans-SNARE complexes but cannot remodel membranes
for fusion.79
It might be expected that in a synthetic system with minimal
machinery that fusion would occur more slowly than in vivo due
to the absence of other components that could facilitate fusion,
for example SNAP and NSF. NSF, stimulated by SNAPs, use ATP
hydrolysis to dissociate the stable SNARE complex and seem to
allow further rounds of fusion to occur. The possibility remains
that they also act to regulate fusion, potentially through the
inhibitory N-terminal domain of t-SNAREs. It is generally
agreed that fusion occurs through a fusion pore, more recently
termed a ‘porosome’, whereby several SNARE complexes form
at the site where fusion is to take place and arrange themselves into
a ring structure giving the membrane a dimpled appearance.80 The
detailed structure of porosomes has been revealed using reconsti-
tuted fusion pores in large unilamellar lipid vesicles (LUVs) and
examined by transmission electron microscopy (TEM). This work
revealed a basket-shaped morphology with a SNARE complex ring
at the base of the fusion pore and also that the porosome was still
functional.81
Measurement of content mixing of large biomolecules
within vesicles can be elegantly performed by incorporation
of fluorescently labelled DNA hairpins inside vesicles. Using
FRET to quantify real fusion events, a decrease in FRET signal
would occur when a labelled DNA strand encounters a
complementary strand from another vesicle.82 This approach
discounted instances of vesicle aggregation or vesicle rupture,
which can obscure actual membrane fusion, and allows a
highly reliable method for detecting fusion. Adopting this
method showed that SNARE complex alone is the minimal
machinery required for fusion pore formation and expansion
(large enough to allow cargo transfer up to 11 kDa).
An interesting characteristic of SNARE proteins is their
preference for phase-separated lipid bilayers, or lipid ‘rafts’,
as it was suggested from in vivo work showing SNAREs’ pre-
ference for cholesterol-rich regions. Lipid rafts represent liquid-
ordered regions of the membrane, rich in saturated lipids and
cholesterol, which act as platforms for an array of interactions
concerned with protein intracellular traﬃcking. These micro-
regions are more ordered and tightly packed than the surrounding
bilayer, but are largely inaccessible to direct observation in vivo.
However, it was found that SNAREs in fact have a higher aﬃnity
for liquid-disordered regions of membrane83 as demonstrated
by monitoring the localisation of fluorescently-labeled SNAREs
reconstituted in phase separated GUVs.
Intriguingly, enveloped viruses also use membrane fusion
machineries to enter a cell. These machineries are functionally
similar to, but mechanistically distinct from the SNAREs.
In analogy to SNAREs, coiled-coil structures are pivotal in the
fusion mechanism of many viral proteins, and the formation of
a low energy membrane structure via the fusion pore. Typical
examples are gp41, a protein that adopts a functional six helix
bundle allowing HIV-1 fusion with the cell membrane,84 and
influenza hemagglutinin, which undergo pH-driven conforma-
tional change to form a fusion-competent coiled coil trimer.85
It has been common to study the membrane interaction of
viral fusion peptide fragments in reconstituted systems to
demonstrate the mechanistic diversity between diﬀerent viral
fusion machineries.86,87 However, an example of functional
reconstitution of a full fusion protein has been reported with
the assembly of the full GPC envelope glycoprotein of
Hemorrhagic-Fever Arenavirus into proteoliposomes. In this
study, pH-dependent fusion was demonstrated using fluores-
cence lipid-mixing and content-mixing assays.88
Membrane bending and fission
Membrane fission shares some similarities with fusion, such
as the formation of a pore-like structure, and the ability to
overcome the energetically unfavourable process of membrane
bending. During fission, vesicle budding occurs either away
from or into the original cellular compartment. Frolov et al.
have recently presented an excellent review on the geometry of
fission.89 Membrane fission is a multistep process that requires
the action by key proteins that initiate the process through
membrane deformation. Well-studied examples of proteins
that remodel the membrane to induce or aid fission are BAR
and ENTH domains, and the ESCRTmachinery. Protein assembly
on the inner or the outer part of membrane compartments
dictate the topology of fission. There are few characterised
mechanisms that promote membrane deformation prior to
fission (Fig. 5). Some protein modules mediate fission by
shaping the exterior of a nascent budded vesicle like clathrin,
and COPI coats, and oligomerised proteins containing ENTH
and BAR domains. A diﬀerent approach is instead used by
ESCRT complexes, which assemble on what will become the
interior surface of the lipid bilayer delimiting a vesicle. For this
reason, ESCRT complexes can also participate in processes
such as cell division, performing the last step of fission of the
plasma membrane.90
BAR and ENTH domains. BAR domain-containing proteins
(Bin–Amphiphysin–Rvs) are curvature-sensing a-helical proteins
that oligomerise to induce further bending in membranes.
The overall topology of BAR domains resembles a banana
shape (Fig. 6a), however there are several subtypes of BAR
domains, that recognise, induce and stabilise different degrees
of curvatures.91 Each BAR domain’s subtype is characterised by a
curved structure specifying if either positive (BAR, N-BAR and
F-BAR) or negative curvature (I-BAR) is introduced in a flat
membrane. Binding of BAR domains to membranes occurs
through specific interaction with lipids and further classification
of BAR domains can be done to reflect their mode of interaction
with membranes. For instance, F-BAR and BAR yeast proteins
involved in endocytosis show different lipid binding preference
when tested in an in vitro system.92 The yeast BAR domain-
containing protein Rvs161/167 preferentially binds to phospha-
tidylinositol 4,5-bisphosphate (PI(4,5)P2), PI(3,4,5)P3 and PI(3)P
showing that the affinity towards lipids increases with additional
phosphate groups i.e. PI(3,4,5)P34 PI(4,5)P24 PI(3)P. In contrast,
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membrane binding affinity does not seem to be affected for F-BAR-
containing proteins by phospholipids’ structure – in fact Syp1 was
even slightly inhibited by dense regions of PI(4,5)P2. Time-lapse
imaging of GUVs incubated with the F-BAR domain of Syp1 and the
BAR domain of Rvs161/167 showed how Rvs161/167 efficiently
can replace Syp1 on the surface of GUVs containing PI(4,5)P2.
The curvature-sensing mechanism for BAR and F-BAR domains
also seems to differ in that BAR domains rely on insertion of an
amphipathic a-helix into the hydrophobic region of the lipid bilayer
(as in the case for Rvs161/167), whereas F-BAR proteins (Syp1 and
Bzz1) sense curvature using a much shallower insertion into the
bilayer, and eventually induce bending via ‘protein crowding’.
Protein crowding causes local membrane bending via the high
lateral pressure that occurs between proteins sitting closely on a
membrane.93 Such crowding, in addition to helix insertion,94 can
induce significant asymmetry in the spontaneous curvature of each
leaflet of the bilayer, driving the membrane to bend. Furthermore,
a recent combined simulation and transmission electron micro-
scopy study of high-density BAR domain interactions suggests
excess adhesive energy combined with local stiffening of the
membrane contribute to curvature-drivenmorphology changes that
can ultimately transform spherical vesicles into tubular networks.95
During BAR domain interactions with the membrane,
lipid clustering can occur.92 The idea of proteins preferentially
binding to liquid ordered phases, namely ‘lipid rafts’, was
previously explored in experiments conducted with SNAREs.
Phosphoinositide-clustering is an eﬀect observed for mamma-
lian I-BAR domains96 but is also displayed by BAR and F-BAR
domains, which eﬀectively ‘freeze’ the dynamics of phosphoi-
nositides and, in turn, whole regions of the membrane rich in
these acidic lipids. The link between sensing curvature and
inducing bending in membranes was an active role proposed
for protein density.97 It is possible to create an environment
where membrane tension, curvature and protein density can be
systematically controlled, using GUVs as a membrane model
system. Optical tweezers can be used to create nanotubes with
diﬀerent shape and sizes by pulling of membranes from
GUVs. Protein density at the GUV surface and tubules can be
measured by fluorescence, whereas the pulling force and tube
radius gives a measure of curvature and tension. The radius of
the tubules is directly proportional to membrane tension in the
GUV. When the interaction of amphiphysin (an N-BAR protein
enriched at clathrin coated necks during endocytosis) with
membranes is analysed vs. degree of curvature and tension,
simultaneous roles of BAR proteins as curvature sensors and
inducers are revealed.50 For instance, low densities of amphi-
physin sense but do not significantly induce curvature. At high
densities, amphiphysin strongly deforms membranes via the
formation of a scaﬀold (Fig. 6b). Similar behaviour was also
observed previously for dynamin, a GTPase involved in
membrane fission and for endophilin, an endocytic protein
enriched at neural synapses.98,99
Some BAR domain containing proteins can be regulated by
autoinhibition such as in the case of pacsin. Pacsin is a F-BAR
protein found primarily in neurons that can be studied
in vitro using liposomes enriched with Folch lipids (a type
of lipid found primarily in brain tissue for signalling). The
interaction between pacsin and dynamin (an F-BAR contain-
ing protein) demonstrated how diﬀerent BAR domain-
containing proteins can eﬃciently regulate each other. It
has been shown that pacsin exists in an autoinhibited state
in vitro and in vivo.100 Full length pacsin binds with less
aﬃnity to the membrane than its F-BAR domain alone and
also prefers less curved surfaces. In comparison, endophilin,
an N-BAR protein does not show any significant diﬀerence in
membrane deformation activity between full-length endophi-
lin and its N-BAR domain alone. This evidence suggests that
N-BAR proteins may induce curvature by a diﬀerent mecha-
nism to F-BAR proteins, possibly such as protein insertion
Fig. 5 Membrane remodelling proteins use various methods in order to
generate curvature. During protein insertion, hydrophobic protein
domains asymmetrically inserted in the lipid bilayer generate membrane
curvature; this is a mechanism used by some BAR proteins. In protein
crowding, it is assumed that the energy for membrane deformation is
generated by collisions between proteins in close proximity on the surface.
This mechanism of membrane deformation is possibly used by BAR and
ENTH proteins in addition to insertion into bilayers. Protein shape defines a
mechanism where membrane bending is generated by curved shaped
proteins with lipid binding domains, such as clathrin and COPI coats.
Regions of negative and positive curvature are indicated (blue). Last, in
protein scaﬀolding, membrane curvature is generated by assembling an
organised protein scaﬀold or ‘lattice’ structure. Membrane deformation
can occur where components of the scaﬀold are anchored to the
membrane through protein–lipid interactions or as shown by adaptor
proteins (green); this method is used by ESCRT proteins.
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and that relieving F-BAR proteins autoinhibition is a mechanism
to regulate membrane deformation.
In contrast to BAR domains, ENTH domain structures are
not naturally curved but utilise an N-terminal amphipathic
helix to ‘wedge’ into membranes promoting deformation and
even tubulation at high concentrations. Epsin NH2-terminal
homology (ENTH) domain is a membrane-binding motif first
identified in the endocytotic protein, epsin. The ENTH domain
can bind to certain acidic lipids, particularly phospholipids,
including PI(4,5)P2 and PI(1,4,5)P3. ENTH-domain proteins are
involved in clathrin-mediated membrane budding, whereby a
clathrin protein coat forms around budding vesicles. In parti-
cular, ENTH proteins can recruit clathrin adaptors to the site of
membrane budding enabling regulation and organisation of
clathrin on membranes. In vitro, isolated ENTH domains
promote fission of vesicles when added to lipid bilayers but
cannot act in concert like BAR domains and facilitate
membrane fission generated by dynamin.101
ESCRT complexes. Sequestering of transmembrane growth
factor receptors is how a cell regulates its survival. The multi-
vesicular body (MVB) pathway is the main membrane transport
system that is responsible for transmembrane cargo recycling
or degradation. The endosomal sorting complexes required for
transport (ESCRT) complex is a set of evolutionally conserved
proteins involved in fission events that drive the ‘maturation’ of
MVBs from early endosomes. The MVB represents a large
membrane-delimited container filled with cargo-loaded intra-
luminal vesicles (Fig. 3). In contrast to other budding mechan-
isms, generation of MVB is a process where membrane
deformation occurs away from the cytosol.
The ESCRT machinery consists of four distinct complexes
generally acting in sequential mechanism. ESCRT-0 and ESCRT-I
Fig. 6 Mechanism ofmembrane fusion and fission by BAR domains (a) structure of the N-BAR domain of hBRAP1/B1N2 showing the curved shape of the dimer
(pdb code 4I1Q). (b) BAR domain sensing membrane curvature through its structure and shaping further bending via oligomerisation. The colour coding of
protein chains represented by the crystallographic structures is identical to colour coding used for the protein subunits in the cartoon representations.
Fig. 7 Generation of intraluminal vesicular compartments by the core ESCRT membrane scission machinery. (I) Initial membrane bending by ESCRT-II
(green cylinders) and seeding of ESCRT-III assembly. (II) The subunit Vps20 (red triangle) initiates Snf7 polymerisation and ESCRT-III propagation into a
spiral filament (blue beaded assembly). The three-dimensional spiral topology of ESCRT-III induces further membrane invagination and defines the size
of the vesicle neck. A capping subunit (purple cube, Vps24) stops filament elongation. (III) Neck constriction and scission of the intraluminal budded
vesicle occurs via Vps4-mediated ESCRT-III polymer disassembly. The ATPase Vps4 binds the ESCRT-III filament via the anchor subunit (Vps2, golden
bead) (IV) Full ESCRT-III disassembly in preparation for a second round of intraluminal vesicle formation (ILV).
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perform specific cargo recognition and concentration at sites of
MVB intraluminal vesicle formation, whereas ESCRT-II interacts
with and anchors to acidic lipids in the endosomal membrane
allowingESCRT-III to formanorganised structureon themembrane
surface at the site of fission and initiate budding102 (Fig. 7). ESCRT-III
is the core membrane scission machinery that performs membrane
fission. It creates filamentous circular arrays from polymerisation of
its subunits, delineating spirals narrowing in size and ultimately
generating variable size necks for nascent vesicles.103
Much is known about the structure of the filament array
of ESCRTs and how they sequester cargo into intraluminal
vesicles, however it is only recently that reconstitution of
MVB formation has been successfully reproduced. Elegant work
using GUVs demonstrated a coordinated assembly of ESCRT
complexes on phospholipid capable of inducing a region of
negative curvature that initiates budding and stabilises the
neck of a nascent vesicle. Ultimately, narrowing of the vesicle
neck by gradual disassembly of the complex drives intraluminal
vesicle fission. In analogy to BAR domains, ESCRT-III proteins
exist in an autoinhibited state, which has to be released for
initiating complex assembly. The enzyme VPS4 provides the
mechano-chemical force necessary to activate ESCRT-III for
assembly on the endosomal membrane, disassembly of the
complex and ultimately recycling ESCRT subunits, returning
them in the monomeric inhibited state. This assembly-
disassembly cycle allows for further rounds of fission to occur
thereby generating continuous cargo encapsulation.104–106
So far, we can only predict via computational modelling
how ESCRT-III polymers generate inward budding in membranes.
In the ‘dome’ model, ESCRT-III polymers assembled into a three-
dimensional spiral define the necks of a nascent vesicle and provide
the physical force to push the membrane.107 In the ‘coatless’ model,
ESCRT complexes localise only at the neck region of nascent
membrane buds and bend the membrane aided by inducing lateral
lipid phase separation.108–110 Intriguingly, the high redundancy of
ESCRT-III in Nature suggests that varying the content of different
ESCRT-III subunits may give origins to different polymeric
structures,111 possibly generating vesicles of different sizes.
Supporting membrane structure and
dynamics
Changes in cell shape control fundamental processes such as
cell division and cell motility. Building cells from scratch or
creating transport systems mimicking cellular structures
requires reconstitution of an organised cytoskeleton interacting
with a membrane. Here we will review some of the reconstitution
studies of cytoskeletal components for the purpose of investigating
the mechanisms of membrane shaping.
Keeping in shape and keeping active: the role of cytoskeleton in
membrane deformation
The cytoskeleton provides membrane structures with shape con-
trol through mechanical modulation of networks of filamentous
protein polymers. The major players in cellular shape change
are the actin cytoskeleton that dynamically changes membrane
morphology, and tubulin, which following polymerisation,
supplies the tracks onto whichmembrane vesicles transport cargo
across a larger organelle. Actin filamentous networks provide the
necessary membrane tension for shaping membranes into pro-
trusions and invaginations or simply to provide a framework for
stability. Furthermore microtubules and actin filaments display
directionality of polymerisation, a property conferred by their
coupling to molecular motors.
Experimental approaches employing supported lipid bilayers
and liposomes have helped to shed light on the mechanism of
membrane shaping through actin polymerisation. An increasing
number of in vitro studies have demonstrated how to successfully
reconstitute actin networks inside and outside liposomes112 or on
lipid bilayers.113 A reconstituted actin cytoskeleton can be coupled
to a vesicle’s interior to provide mechanical shape and stability
to the membrane compartment. For instance, spectrin, a cyto-
skeletal protein component of erythroid cells, can be reconstituted
as a shell at the outer membrane of GUVs by addition of ATP,
providing a rigid framework for vesicle shape.114 Co-encapsulation
of myosin motors with actin filaments induces contraction of the
meshwork, ultimately reproducing membrane contractility.115
In vitro reconstitution studies of actin shells anchored outside or
inside liposomes have revealed how the strength of anchoring to
membranes controls cortical actin remodelling,116 providing a
simple model for polarity of actin shells and mechanistic basis
for a cell’s movement. When actin layers are assembled and
anchored outside liposomes, the action of molecular motors
generates cortical tension, which results in opposite eﬀects on
the membranes. High tension causes cortical actin to retract to one
side of the liposome, whereas low tension coupled with strong
anchoring between actin and membranes, results in vesicles
shrinkage. In a model where an actin shell is assembled and
anchored inside liposome vesicles, actomyosin filaments retract
away from the membrane if the strength of anchoring is weak,
whereas they are pulled towards the membrane when the attach-
ment of the cortex is strong.
The cytoskeleton is also crucial for facilitating membrane
scission in cell division events. For instance, a reconstituted
minimal complex of a bacterial homologue of tubulin (FtsZ),
and a single accessory protein (FtsA) has been shown to be
competent for cell division when incorporated into liposome
vesicles.117 The beautiful simplicity of the bacterial division
machinery demonstrates that the main requirement for membrane
severing is an organised assembly of proteins, without the need for
excess membrane.
However, cytoskeletal cortices do not only play an active role in
moulding a cell’s plasma membrane but they define shape
changes of intracellular membrane compartments. Membrane
tubulation is an event initiated either by proteins that can scaﬀold
positive membrane curvature (such as COPI or BAR proteins), or
generated by the pulling forces of molecular motors attached to
localised regions of the organelle’s membrane. Growth and
retraction of membrane tubules from larger organelles is another
mean of cargo transport in the membrane traﬃcking system of
a cell, in addition to vesicles. This dynamic motion of tubular
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structures is due to the presence of molecular motors that can
walk along the fast growing tip of cytoskeletal microtubules (plus
end motors, e.g. kinesins) or in the opposite direction (minus end
motors, e.g. dyneins). Reconstitution of membrane tubule ‘pull-
ing’ processes has been reproduced using both cell extracts and
minimal components.118 An alternative means to generate tubu-
lation is to ‘push’ from the inside of a vesicle. Encapsulated
microtubule components can create long protrusions when poly-
merisation is induced.119
Curvaceous models: membrane
elasticity theory
Theoretical modeling combined with in vitro model systems is a
powerful tool to characterise and quantify the physical properties of
the protein components of this membrane remodelling toolbox.
When the proteins or protein complexes reviewed above interact
with membranes, they generate changes in the shape or structure
of the membrane interface. Theoretical models to understand
these processes usually use the Helfrich Hamiltonian.120 This is a
phenomenological model for membrane elasticity proposed by
Wolfgang Helfrich in 1973.121 The membrane is treated using a
continuummodel where the lipid bilayer is considered to be a fluid
elastic sheet, i.e., the molecular scale details of the membrane
structure are averaged out into bulk mechanical properties of the
bilayer that determine its behaviour. This model also assumes
that the membrane is a thin sheet such that the thickness of
the membrane is very small compared to the lateral extent of the
membrane surface. The Helfrich Hamiltonian ( felastic) describes
the elastic contribution (per unit area) to the free energy of the
membrane,
felastic = fbend + fstretch (1)
where fbend is the free energy per unit area due to membrane
bending and fstretch is the free energy per unit area due to
membrane stretching.
The stretching term fstretch = t, where t is the surface tension of
the membrane. This term is often neglected as the energy cost of
stretching a lipid membrane is much greater than that of bending
the membrane. Therefore, in many cases the stretching of the
membrane is not considered to be significant.Membrane stretching
can also be described by an elastic area expansion modulus (KA),
where the change in free energy per unit area upon stretching
the membrane Dfstretch = (KA/2)[DA/A0]
2, where DA is the change in
membrane area and A0 is the initial membrane area.
Typical values for KA for lipid membranes have been found
to be in the range 0.1–0.2 J m2, or 25–50kBT nm
2.122 It should
be noted that lipid membranes are not particularly stable under
stretching deformations; they rupture upon fractional area
increases (DA/A0) between 2–5%.
123–125
The bending contribution to the free energy of a membrane
is therefore the most significant. This can be described by two
mechanical moduli:
fbend ¼ kb
2
2H  C0ð Þ2þkGG (2)
where kb is the bending modulus and kG is the Gaussian
curvature modulus. H represents the mean curvature of the
membrane, which is the mean of the two principal curvatures
(Ci; i = 1, 2), H = (C1 + C2)/2. G represents the Gaussian curvature
of the membrane, which is also defined by the principal
curvatures, G = C1C2. Finally, C0 is the spontaneous or preferred
curvature of the membrane; this is the curvature that the
membrane adopts in its relaxed state and is the minimum
curvature energy state of the membrane. It should be noted that
these are the first two terms in an infinite expansion in H2 and
G, where the higher order terms in these variables are assumed
to be small. Therefore this model is most accurate for small
bending deformations about the equilibriummembrane shape.
Higher order mechanical moduli, e.g. for terms in H4 and G2,
have not been determined experimentally, therefore this model
is also often applied to model systems where the bending
deformation is large.
It has been shown that values for the Gaussian modulus
kG are constrained by the bending modulus kb such that 1r
kG/kb r 0.7 kG is challenging to determine directly from
experiments, but the few experimental studies of kG in amphi-
phile systems have found that kG E 0.8kb.126,127 Conveni-
ently, due to the Gauss–Bonnet theorem, the Gaussian
curvature term in eqn 2 only contributes to the change in free
energy of the system if the membrane undergoes a topological
transition (e.g. fusion, fission, poration). The Gaussian elasticity
term can therefore be ignored for bending of a membrane
of fixed topology, i.e. when only considering the membrane
bending capabilities of these proteins, prior to scission, merger
or poration events that may occur later in the membrane
remodelling process.
Eqn 2 can also often be further simplified due to the fact
that the lipid composition of the membrane is symmetric
across the membrane for almost all experimental model
membrane systems. When topological changes in the
membrane do occur, it is often useful to treat the elastic
energies of the two lipid monolayers of the membrane sepa-
rately with a finite spontaneous curvature, C0. However for
bending at fixed topology, the elastic energy of the whole lipid
bilayer is considered together and due to the symmetry of the
lipid composition in each monolayer, C0 = 0. Therefore the total
free energy of model membranes for bending at fixed topology
can be simplified to
Felastic =
Ð
felastic dA = 2kb
Ð
H2 dA (3)
where typical values of kb for lipid bilayers are in the range
10–20kBT.
122 Yet it should be noted that the situation is not
always so simple. This model is most appropriate for mem-
branes composed of a single lipid type. For model membranes
composed of lipid mixtures, curvature dependent demixing of
different lipids can occur, increasing the complexity of theore-
tical analysis.128 Indeed, variations in lipid compositions
between different organelles are thought to be highly signifi-
cant in determining the different membrane morphologies and
topologies of these structures.129–131 Beyond the simplest
implementations of this curvature elasticity model, mesoscale
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computational modelling approaches are often used to investigate
curvature effects during protein–membrane interactions.132,133
An example of the application of theoretical models is the
modelling of the interaction of F-BAR domains with lipid
membranes.134 Combining simulations and membrane elasti-
city theory predicts an initial binding energy of an F-BAR dimer
to the membrane of 4kBT, which reduces to 2.3kBT at equili-
brium during membrane tubulation. Therefore this shows that
single F-BAR dimers at low density on a membrane would not
individually be able to generate enough energy to bend a
membrane with a bending modulus of 20kBT. Multiple F-BAR
dimers would be required to act in concert at high density on a
membrane in order to manipulate its curvature, in agreement
with experimental observations reviewed above.
Ultimately, it should be noted that although the Helfrich
model considers the membrane to be a continuous sheet with
no molecular details. However, the membrane mechanical
moduli in this model can be directly related to the intermole-
cular interactions between lipids by considering the lateral
stress profile in the membrane.135,136 This can allow considera-
tion of protein-induced changes in the mechanical moduli
of membranes due to the ways in which proteins modulate
the interactions between lipids, for example by direct insertion
of part of the protein complex into the membrane.137
Finally, it is worth highlighting that computational studies
have also proved an extremely practical tool to provide suggestive
insights into the molecular-scale mechanisms of membrane
remodelling processes, and interactions between membranes
and protein complexes. While the focus of this perspective is
the in vitro reconstitution of membrane remodelling machineries,
there is a wealth of literature in which computer simulation
approaches have provided new mechanistic ideas impossible to
gather by traditional experimental work. In addition to the work
on the F-BAR domain discussed above, important contributions
to the possible molecular mechanisms underlying membrane
remodelling include simulations of the membrane interactions
of N-BAR domains138,139 and SNARE proteins.140,141
Rationalisation of the toolbox for
membrane remodelling
If natural protein components are to be used as tools to
generate new functional synthetic cell-like materials, they will
need to be easy to handle and compatible with other compo-
nents when incorporated into more complex systems. It would
be highly challenging to engineer synthetic cells from compo-
nent parts that were not well characterised and simplified
machineries. The highly elaborate nature of many of these
natural protein complexes is designed for optimal function in
complex in vivo cellular environments. This complexity is
unlikely to be required when protein complexes are used as
parts within minimal in vitro systems. There are two possible
approaches to developing simplified minimal components
for an in vitromembrane remodelling toolbox: (i) to use protein
engineering to redesign the proteins as minimal systems
without additional, redundant functionality; (ii) to take inspira-
tion from the function of these proteins to design novel, synthetic
components that perform the required in vitro tasks. Little work
has been done to establish such minimal machineries but
examples of success in this approach will be given below.
Looking to the future: is the design of minimal systems for
moulding membranes possible?
Minimal protein-based systems acting upon membranes are
surely useful to investigate mechanisms of membrane remodel-
ling but they also provide us with a framework for extracting
basic design rules for function, which can then be employed for
creating reduced systems. To date, several protein complexes
have been simplified or even de novo designed for membrane
fusion, fission and vesicle transport. The SNARE system
for membrane fusion is certainly the most amenable to repro-
duction. SNAREs function on a simple principle: bringing
membrane bilayers into close physical proximity by means of
formation of an extremely stable protein complex. Bioinspired
systems based on this principle have been created by de novo
designing a minimal SNARE pair from complementary coiled
coil peptides. The reduced SNARE system for membrane fusion
is based on a simple heterodimeric coiled coil pair and has
been subsequently refined by including moieties for membrane
anchoring.142,143 Intriguingly, most protein complexes involved
in membrane remodelling are held together by coiled coil
interactions. For instance, the structural features of BAR
domains are arrays of anti-parallel a-helical coiled-coils adopting
curved shapes and using a positively charged surface to interact
with lipids. The extensive knowledge we have acquired in the area
of coiled coil design,144,145 including the computational-guided
de novo design of protein assembly curvature,146 make the engi-
neering of functional membrane sculpting systems more achiev-
able. Coiled coil modules have already been extensively used as
cytoskeleton biomimicry147 and recently, have been designed to
self-assemble into organised cages resembling the structure of
clathrin coats.148,149 It is not too far fetched to think that soon we
could use these systems to design de novomembrane remodelling
tools from the bottom up.
Engineering of a minimal machinery that performsmembrane
fission in a controllable manner is however challenging. Any
curvature-inducing protein system can eventually promote
membrane fission at high densities. However, the creation of
new vesicles in a controlled manner requires a multistep mecha-
nism including factors to induce initial membrane bending
(Clathrin and COPI coats and even actin filaments), entities
to stabilise and promote further budding (BAR and ENTH
domain-containing proteins) and regulatory factors that promote
membrane fission mechanically-driven by nucleotide hydrolysis
(dynamin). Since the development of the PURE system for in vitro
protein expression, assembling a minimal machinery to recreate
cell division using model membranes has moved a step closer.
In situ expression of membrane deforming proteins using the
PURE system has been shown to produce extensive membrane
deformation in liposomes preparations upon the activity of
expressed N-BAR domains.150
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Initiation of membrane scission in a model vesicle, for
mimicking a dividing cell, is a process that must begin from
the lumen of the vesicle and requires proteins that can generate
narrow necks and induce negative curvature, such as I-BAR
proteins or ESCRT complexes. In situ expression of minimal
ESCRT machineries inside GUVs or liposomes could be the
first step towards recreating membrane-bound compartments
competent for cell division. The drawback of using complexes
such as ESCRTs is the high redundancy of the functional
assembly, making reconstitution of such a system for large
scale production (e.g. for biotechnology applications) challenging.
Monocellular ancient organisms such as archea bacteria, for
instance, utilise ESCRT complexes with a reduced number of
components in comparison to yeast or humans, given their
simpler metabolism. These ESCRTs modules can be regarded
as a source or an inspiration for assembly of ‘divisomes’, or
remodelling of membranes with appropriate lipid composition.151
Interesting developments in the design of minimal vesicular
transport systems include coupling of liposomes to molecular
motors capable of walking on molecular tracks. Liposomes
coated with bundled actin have been used to build simple
transport systems based on myosin motors.152,153 Complemen-
tary DNA strands are an eﬃcient manner to anchor membrane
vesicles to a kinesin molecule gliding on microtubules.154 In
such system, loading, transport and unloading of fluorescent
cargo-loaded liposomes can be reproduced using a flow-cell –
tuning of the strength of binding between the DNA strands
allows for vesicle unloading. Alternatively, coupling of cargo
vesicles can be achieved via streptavidin–biotin linkage and
quantum dots coupled to the trailing ends of actomyosin
filaments via capping proteins.155
Inspired by the function of natural proteins, several
synthetic alternatives have been shown to mimic properties of
these proteins at lipid biomembranes. DNA nanotechnology is
proving to be one useful tool in this approach.156 DNA–lipid
conjugates have been successfully applied to mimic SNARE
fusion proteins, membrane adhesion receptors, tetherins and
transmembrane pores.157–160,161 Supramolecular chemistry has
also provided synthetic organic macromolecules that can,
for example, trigger membrane adhesion or poration.162,163
Synthetic nanoparticles may also prove useful mimics of
membrane remodeling proteins in minimal systems. While
much of the existing work on nanoparticle–membrane inter-
actions was not motivated by biomimicry of natural membrane-
active proteins, nanoparticles have been shown to be able to
bend and scaffold the membranes of GUVs.164–167
Outlook: towards engineering
functional protocells with minimal
machineries
We have reviewed examples of the successful in vitro reconsti-
tution of membrane remodeling protein complexes and shown
how these minimal systems have provided new insight into
their in vivo biological properties and functions and their
regulation by other proteins. However towards the higher goal
of using biological components to build synthetic cell-like
materials, much progress needs to be made. Relatively few
examples exist of successful engineering of minimal membrane
remodeling machineries more suited to optimal function
within model membrane systems. Further eﬀorts are required
to generate a toolbox of these specialised in vitro components.
To the best of our knowledge, no work has been reported
that successfully combines two or more of these minimal
membrane machineries into a single system; compatibility of
these components may prove challenging in order to mitigate
mutual interference of membrane interactions and function.
Furthermore, it would be of interest to demonstrate an increase
in the complexity of these reconstituted minimal systems
through coupling membrane remodelling processes with other
functional biomolecular modules, such as mechanosensitive
proteins and channels.168,169
In order to develop advanced minimal cells by bottom-up
assembly techniques that incorporate scaﬀolding, shaping and
membrane vesicle traﬃcking capabilities, we suggest that a
process of development described in Fig. 8 should be followed.
Firstly, the components need to be characterised using bio-
physical investigative approaches. These components then
need to be stripped back to minimal functional entities to
provide maximum simplicity in their design and function. This
process will require multiple iterations between protein
complex redesign and biophysical characterisation. Thirdly,
two or more independent membrane-active components need
to be successfully reconstituted into model systems to demon-
strate mutual compatibility and minimise unwanted inter-
ference between individual components. This will require the
simplified, minimal components to behave in a predictable
manner in how they interface with other components of the
synthetic biology toolbox when combined together in systems
of increasing complexity. Finally, incorporating metabolic
processes within the compartments of synthetic cells can
further increase complexity and functionality.
Fig. 8 The iterative process in the design of a minimal toolbox for
membrane remodelling.
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Nature shows us how control of dynamic chemical compart-
mentalisation is required to regulate a large number of parallel
processes within composite cellular systems; an important
feature that synthetic biologists will wish to harness and
exploit. The pathway to realising functional cell-like materials
has become much clearer over the past 5–10 years with many
significant advances in the understanding, design and applica-
tion of in vitro model membrane–protein interaction systems.
Now the next steps need to be taken in establishing minimal
standardised parts and tools to generate compartmentalisa-
tion, and show that they can be successfully incorporated into
organised functional multicomponent systems of increasing
complexity.
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